Immix Biopharma (IMMX) Selling, General & Administrative (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 647.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -1.52 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 4.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.82 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 837,441.00 |
| Jun 30, 2022 | 953,203.00 |
| Mar 31, 2022 | 700,507.00 |
| Dec 31, 2021 | 589,102.00 |
| Sep 30, 2021 | 318,301.00 |
| Jun 30, 2021 | 180,404.00 |
| Mar 31, 2021 | 137,680.00 |